Yahoo France Recherche Web

Résultats de recherche

  1. Jennifer Anne Doudna (/ daʊdnə /), née le 19 février 1964 à Washington, est une professeure américaine de biochimie et de biologie moléculaire à l'université de Californie à Berkeley [1], [2]. Spécialiste de l'ARN, elle fait depuis 1997 partie des investigateurs soutenus par le Howard Hughes Medical Institute [3].

  2. Jennifer Anne Doudna ForMemRS (/ ˈ d aʊ d n ə /; born February 19, 1964) is an American biochemist who has done pioneering work in CRISPR gene editing, and made other fundamental contributions in biochemistry and genetics. Doudna was one of the first women to share a Nobel in the sciences.

  3. Les deux chercheuses ont découvert les ciseaux génétiques CRISPR/Cas9, une technique révolutionnaire pour modifier l'ADN de n'importe quel organisme. Le prix Nobel de chimie 2020 leur a été décerné pour leur collaboration transfrontalière et pluridisciplinaire.

  4. 9 mai 2024 · DNA. CRISPR. On the Web: The Nobel Prize - Jennifer A. Doudna (May 03, 2024) Jennifer Doudna (born February 19, 1964, Washington, D.C.) is an American biochemist best known for her discovery, with French microbiologist Emmanuelle Charpentier, of a molecular tool known as clustered regularly interspaced short palindromic repeats ...

    • Kara Rogers
  5. Jennifer Doudna is a chemist and biologist who discovered CRISPR-Cas9, a tool for genome editing. She is the Li Ka Shing Chancellor’s Chair in Biomedical and Health Sciences at UC Berkeley and leads the Innovative Genomics Institute.

    • Jennifer Doudna1
    • Jennifer Doudna2
    • Jennifer Doudna3
    • Jennifer Doudna4
  6. Jennifer A. Doudna The Nobel Prize in Chemistry 2020. Born: 19 February 1964, Washington, D.C., USA. Affiliation at the time of the award: University of California, Berkeley, CA, USA. Prize motivation: “for the development of a method for genome editing” Prize share: 1/2. Work.

  7. 7 oct. 2020 · Doudna and Emmanuelle Charpentier are honored for their discovery of the CRISPR–Cas9 system, a revolutionary tool for genome engineering. The Nobel committee praises the technology as a “game-changer” for the life sciences and beyond.